Microvesicle-associated AAV Vector as a Novel Gene Delivery System

Maguire, Casey A, Balaj, Leonora, Sivaraman, Sarada, Crommentuijn, Matheus HW, Ericsson, Maria, Mincheva-Nilsson, Lucia, Baranov, Vladimir, Gianni, Davide +4 more·2012·Molecular Therapy
DOI 10.1038/mt.2011.303

Cited by (282)

Items 201–282 of 282

  1. Exploring AAV‐Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential
    Fan Wu, Wuhui He, Yun Xiao, Qiong Wu, Qing Zhang, Tiesong Zhang, Lei Xu, Xinyi Pang · 2025 · Advanced Science
  2. “Don’t eat me/eat me”-combined apoptotic body analogues for efficient targeted therapy of triple-negative breast cancer
    Kai‐Long Zhang, Huanru Fu, Chao Xing, Yi Luo, Fangfang Cheng, Qiang Fu, Yujie Huang, Longxin Qiu · 2021 · Journal of Materials Chemistry B
  3. Current trends in gene therapy to treat inherited disorders of the brain
    Żaneta Matuszek, Brandon L. Brown, Carolyn M. Yrigollen, Megan S. Keiser, Beverly L. Davidson · 2025 · Molecular Therapy
  4. Evading the AAV Immune Response in Mucopolysaccharidoses
    Matthew Piechnik, Kazuki Sawamoto, Hidenori Ohnishi, Norio Kawamoto, Yasuhiko Ago, Shunji Tomatsu · 2020 · International Journal of Molecular Sciences
  5. On the Relationship of Viral Particles and Extracellular Vesicles: Implications for Viral Vector Technology
    Christoph Metzner, Marianne Zaruba · 2021 · Viruses
  6. Exosome-Modified AAV Gene Therapy Attenuates Autoimmune Hepatitis via Enhanced Regulatory T Cell Targeting and Immune Modulation
    Wenwei Shao, Weilin Huang, Yixuan Wang, Helin Sima, Kai Ma, Rongtao Chen, Heqiao Han, Yixuan Yang, Yuchen Bao, Xiaolei Pei et al. · 2025 · Microorganisms
  7. Tissue blood volumes and weights in adult beagle dogs.
    R.G. Cuddihy, Russell P. Hall, CHARLES H. HOBBS, Bruce B. Boecker, Bruce A. Muggenburg · 1972 · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
  8. Tracking of Human Parvovirus B19 Virus-Like Particles Using Short Peptide Tags Reveals a Membrane-Associated Extracellular Release of These Particles
    Kotaro Ishida, Takafumi Noguchi, Sakika Kimura, Hidehiko Suzuki, Hirotaka Ebina, Eiji Morita · 2023 · Journal of Virology
  9. Signed, Sealed, Delivered: Microenvironmental Modulation of Extracellular Vesicle-Dependent Immunoregulation in the Lung
    Daniel J. Schneider, Jennifer M. Speth, Marc L. Peters-Golden · 2016 · Frontiers in Cell and Developmental Biology
  10. Exosomes in multidrug-resistant cancer
    Dnyaneshwar Kalyane, Devendra Choudhary, Suryanarayana Polaka, Hanmant Goykar, Neelima Anup, Vishakha Tambe, Kiran Kalia, Rakesh Kumar Tekade · 2020 · Current Opinion in Pharmacology
  11. Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier
    Yanning Bao, Weiyue Lu · 2023 · Expert Opinion on Drug Delivery
  12. EV, Microvesicles/MicroRNAs and Stem Cells in Cancer
    Jacob A Tickner, Derek J. Richard, Kenneth John O'Byrne · 2018 · Advances in experimental medicine and biology
  13. The brain-joint axis: links between osteoarthritis and neurodegenerative disorders in aging
    Mostafa Adel Rabie, Henning Madry, Magali Cucchiarini, Nesrine S. El Sayed · 2025 · Journal of Advanced Research
  14. Engineered small extracellular vesicles as a novel platform to suppress human oncovirus-associated cancers
    Iman Owliaee, Mehran Khaledian, Armin Khaghani Boroujeni, Ali Shojaeian · 2023 · Infectious Agents and Cancer
  15. Therapeutic Application of Extracellular Vesicles-Capsulated Adeno-Associated Virus Vector via nSMase2/Smpd3, Satellite, and Immune Cells in Duchenne Muscular Dystrophy
    Yasunari Matsuzaka, Yukihiko Hirai, Kazuo Hashido, Takashi Okada · 2022 · International Journal of Molecular Sciences
  16. Adeno-Associated Viral Vector Mediated Expression of Broadly- Neutralizing Antibodies Against HIV-Hitting a Fast-Moving Target
    Chringma Sherpa, Stuart F.J. Le Grice · 2020 · Current HIV Research
  17. Adeno-Associated Virus Vectors—a Target of Cellular and Humoral Immunity—are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies
    Angela E. Araujo, Martin Bentler, Xabier Perez Garmendia, Asma Kaleem, Claire Fabian, Michael Alexander Morgan, Ulrich Thorsten Hacker, Hildegard Büning · 2024 · Human Gene Therapy
  18. Insights in AAV-mediated antigen-specific immunity and a strategy for AAV vaccine dose reduction through AAV-extracellular vesicle association
    Ester Molina, Marcos Tejero, Ozgun Firat Duzenli, Hisae Kuoch, Colin Caine, Karina Y. Krotova, Michael E. Paulaitis, George Aslanidi · 2024 · Molecular Therapy — Methods & Clinical Development
  19. Identification of the role of SNARE proteins in rAAV vector production through interaction with the viral MAAP
    Çağla Aksu Küz, Kang Ning, Siyuan Hao, Shane McFarlin, Xiu Juan Zhang, Fang Cheng, Jianming Qiu · 2024 · Molecular Therapy — Methods & Clinical Development
  20. Probing aspects of extracellular vesicle associated AAV allows increased vector yield and insight into its transduction and immune-evasive properties
    Ming Liang Cheng, Demitri de la Cruz, Adam V. Crain, Paula Espinoza, Carrie Ng, Zachary C. Elmore, Aravind Asokan, Casey A. Maguire · 2025 · Molecular Therapy — Methods & Clinical Development
  21. The combination of rAAV pseudo-lipid nanoparticle and triamcinolone acetonide enables multi-administration to liver
    Chunmei Gan, Mi Leng, Yu Liu, Zhaoyue Zheng, Shufang He, Wen Qiao, Xiao Lin, Yao Xiao, Jingya Ye, Lixing Zhou et al. · 2024 · Molecular Therapy — Methods & Clinical Development
  22. Exosome-Based Translational Nanomedicine: The Therapeutic Potential for Drug Delivery
    Lei Lv, Qingtan Zeng, Shenjun Wu, Hui Xie, Jiaquan Chen, Xiang Jiang Guo, Chang‐Ning Hao, Xue Zhang, Meng Ye, Lan Zhang · 2015 · Elsevier eBooks
  23. Gene therapy for the heart: encapsulated viruses to the rescue
    Uma Maheswari Deshetty, Susmita Sil, Shilpa J. Buch · 2024 · Extracellular Vesicles and Circulating Nucleic Acids
  24. Metabolic engineering improves transduction efficiency and downstream vector isolation by altering the lipid composition of extracellular vesicle-enclosed AAV
    Paula Espinoza, Ming Liang Cheng, Carrie Ng, Demitri de la Cruz, Elizabeth D Wasson, Deirdre M. McCarthy, Pradeep G. Bhide, Casey A. Maguire, Miguel C. Santoscoy · 2024 · Metabolic Engineering
  25. Modified mRNA-Based Therapeutic Strategies for Myocardial Ischemia–Reperfusion Injury
    Ting Cai, Xiang-Qun Yang · 2025 · International Journal of Molecular Sciences
  26. Impact of Medium-Sized Extracellular Vesicles on the Transduction Efficiency of Adeno-Associated Viruses in Neuronal and Primary Astrocyte Cell Cultures
    Orsolya Tünde Kovács, Eszter Soltész‐Katona, Nikolett Marton, Eszter Baricza, László Hunyady, Gábor Turu, György Nagy · 2021 · International Journal of Molecular Sciences
  27. Capture of adeno‐associated viruses from clarified lysate by continuous flow ultracentrifugation: a comparative study of iodixanol and sucrose gradients
    Sabrina Leigheb, Maral Rahimzadeh, Nikolaus Virgolini, Aiym Tleuova, Mahbod Mousavian, Astrid Dürauer, Patrícia Pereira Aguilar · 2025 · Journal of Chemical Technology & Biotechnology
  28. Diagnostic and Therapeutic Applications of Exosome Nanovesicles in Lung Cancer: State-of-The-Art
    Amirhossein Sahebkar, Rezvan Mohammadi, Seyede Atefe Hosseini, Somaye Noruzi, Ailin Ebrahimzadeh · 2021 · Anti-Cancer Agents in Medicinal Chemistry
  29. Trans-trigeminal transport of masseter-derived neprilysin to hippocampus
    Yukinori Kuwajima, Manavi Nagai, Cliff Lee, Albert M. Galaburda, Takuya Kobayashi, Ayaka Nakasato, John Daren Da Silva, Shigemi Nagai, Masazumi Nagai · 2020 · Archives of Oral Biology
  30. Revolutionizing therapeutics: unleashing the power of extracellular vesicles for disease intervention
    Sayam Ghosal, Bernadett R. Bodnár, Brachyahu Meir Kestecher, Ákos Nagy, Tamás László, Bora Yilmaz, Yixuan Zeng, Adrienn Szabó, Csaba Bödör, Edit I. Buzás et al. · 2025 · Current Opinion in Physiology
  31. Optimization of an adeno-associated viral vector for epidermal keratinocytes in vitro and in vivo
    Qi Shen, Shogo Suga, Yuta Moriwaki, Zening Du, Emi Aizawa, Mutsumi Okazaki, Juan Carlos Izpisúa Belmonte, Yusuke Hirabayashi, Keiichiro Suzuki, Masakazu Kurita · 2024 · Journal of Dermatological Science
  32. Extracellular Vesicles Move Toward Use in Clinical Laboratories
    Lindsay Nicole Strotman, Mark W. Linder · 2016 · Clinics in Laboratory Medicine
  33. CRISPR-mediated optogene expression from a cell-specific endogenous promoter in retinal ON-bipolar cells to restore vision
    Andrea Maddalena, Sonja Kleinlogel · 2023 · Frontiers in Drug Delivery
  34. Enhanced recovery of CD9-positive extracellular vesicles from human specimens by chelating reagent
    Ayako Kurimoto, Yuki Kawasaki, Toshiki Ueda, Tatsutoshi Inuzuka · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  35. Extracellular vesicles-associated AAVs for the treatment of Machado-Joseph disease
    Carina Henriques, Patrícia R. de Albuquerque, David Rufino‐Ramos, Miguel Monteiro Lopes, Kevin Leandro, Catarina O. Miranda, Rita Almeida, Guilherme Lopes-Gabriel, João de Sousa-Lourenço, Sara Lopes et al. · 2025 · Molecular Therapy
  36. Adeno-associated Virus-Mediated Gene Delivery Across the Blood-Brain Barrier
    Yizheng Yao, Fengfeng Bei · 2024 · Advances in neurobiology
  37. MA104 cell line is permissive for human bocavirus 1 infection
    Jielin Tang, Sijie Chen, Yijun Deng, Junjun Liu, Dan Feng Huang, Muqing Fu, Bao Xue, Canyu Liu, Chunchen Wu, Fan Wang et al. · 2025 · Journal of Virology
  38. Accessorizing viral vectors with extracellular vesicles for enhanced performance
    Casey A. Maguire · 2023 · Molecular Therapy
  39. Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno‐associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation
    Mengzhen Xie, Lixiang Wang, Yingping Deng, Ke Ma, Hongbo Yin, Xiaolan Zhang, Xingye Xiang, Jin Tang · 2024 · Journal of Ophthalmology
  40. Adeno-Associated Virus 5 Transduces Adipose-Derived Stem Cells with Greater Efficacy Than Other Adeno-Associated Viral Serotypes
    Priyanka Sharma, Sunishka M. Wimalawansa, Gregory C. Gould, Ron Michael Johnson, Katherine J. D. A. Excoffon · 2016 · Human Gene Therapy Methods
  41. Virus Immune Evasion: New Mechanism and Implications in Disease Outcome
    Rika Draenert, John Frater, Júlia G. Prado · 2012 · Advances in Virology
  42. Exosome nanocarriers
    Jasvinder Singh Bhatti, Rajesh Vijayvergiya, Bhupinder Singh, Gurjit Kaur Bhatti · 2019 · Elsevier eBooks
  43. Extracellular vesicles in neurological disorders: emerging roles and underlying molecular mechanisms
    Mst. Afsana Mimi, Md. Mahmudul Hasan · 2025 · Exploration of neuroscience · Retracted
  44. Methods and strategies of bioengineered cell exosomes for the treatment of osteoarthritis
    Chengjun Zhang, Jinming Liu, Shijie Chen, Dacheng Zhao, Changshun Chen, Bin Geng, Yayi Xia · 2025 · Joint Bone Spine
  45. Advances in oncolytic virus delivery strategies and challenges in clinical translation
    Yu Guo, Chunyao Huang, Lihua Xu, Yujing Xuan, Pengju Wang · 2026 · Materials Today Bio
  46. Enhanced cellular secretion of AAV2 by expression of foreign viral envelope proteins
    Melissa A. Kotterman, James T. Koerber, Jung-soo Nam, Young-hoo Cho, Seung‐Hyun Kim, Jae-hyung Jang, Kwang‐il Lim · 2014 · Biochemical Engineering Journal
  47. Membranous Bubbles: High-Purity and High-Titer Exosomes as the Potential Solution for Adeno-Associated Viruses to Evade Neutralization?
    Manish Muhuri, Guangping Gao · 2021 · Human Gene Therapy
  48. Nanoshield‐Assisted Viral Gene Therapy with Induction of Non‐Apoptotic Cell Death and Durable Antitumor Immunity
    Soo‐Hwan Lee, Yun‐Kyeong Cho, Seunghwan Bang, Daeun Sung, Jahyun Koo, Seoyoung Kim, Youngil Koh, Hojun Kim, Hyojin Lee · 2025 · Advanced Science
  49. Exosome Mediated Delivery of Paclitaxel for the Treatment of Multi-Drug Resistant Pulmonary Metastases
    Kim, Myung Soo · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  50. Adeno-Associated Virus Vector Design–Moving the Adeno-Associated Virus to a Bioengineered Therapeutic Nanoparticle
    Nico Martin Jäschke, Hildegard Büning · 2022 · Hematology/Oncology Clinics of North America
  51. Light- Scattering Methods to Characterize Extracellular Vesicles
    Paul Harrison, Chris Gardiner, Ian L. Sargent · 2014
  52. Gene therapy to terminate tachyarrhythmias
    Kohei Kawajiri, Kensuke Ihara, Tetsuo Sasano · 2022 · Expert Review of Cardiovascular Therapy
  53. Encapsulation of AAVs into Protein Vault Nanoparticles as a Novel Solution to Gene Therapy’s Neutralizing Antibody Problem
    Logan Thrasher Collins, Wandy L. Beatty, Buhle Moyo, Michele Alves‐Bezerra, Ayrea E. Hurley, Qing Lou, Z. Hong Zhou, William R. Lagor, Gang Bao, Selvarangan Ponnazhagan et al. · 2026 · ACS Synthetic Biology
  54. In vivo selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cord
    Killian S. Hanlon, Ming Liang Cheng, Demitri de la Cruz, Nikita J. Patel, Miguel C. Santoscoy, Yi Gong, Carrie Ng, Diane M. Nguyen, Josette Nammour, Sean W. Clark et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Extracellular Vesicles: The Challenges on the Way and Engineering Perspectives
    Noha Attia, Heba G. Ibrahim, Heba Abdulla, Mohamed Mashal, Gustavo Puras, José Luís Pedraz · 2024 · Springer eBooks
  56. Micelles, Liposomes, and Extracellular Vesicles: Lipid Nanovesicles for Central Nervous System Drug Delivery
    Brandon M. Lehrich, Yaxuan Liang, Massimo S. Fiandaca · 2024 · Springer eBooks
  57. Significant Enhancement of Adeno‐Associated Virus Vector Yield for Gene Therapy Using Multidimensional Optimization Strategies
    Weiqiang Shen, Shuyuan Chen, Zhongwan Li, Wei Yu · 2025 · The FASEB Journal
  58. Distinguishing Pseudotransduction and True Transduction Enables Characterization and Bioengineering of Extracellular Vesicle‐Adeno‐Associated Virus Vectors
    Jonathan D. Boucher, Devin M. Stranford, Hailey I. Edelstein, Danielle Tullman‐Ercek, Neha P. Kamat, Joshua N. Leonard · 2026 · Journal of Extracellular Vesicles
  59. What’s next for osteoarthritis gene therapy?
    Christopher H. Evans, Steven C. Ghivizzani, Annahita Keravala, Thomas W. Chalberg, Paul D. Robbins · 2026 · Frontiers in Bioengineering and Biotechnology
  60. Detection of Human c-Myc and EGFR Amplifications in Circulating Extracellular Vesicles in Mouse Tumour Models
    Leonora Balaj, Fatemeh Momen‐Heravi, Weilin Chen, Sarada Sivaraman, Xuan Zhang, Nicole Ludwig, Eckart U. Meese, Thomas D. Wurdinger, David P. Noske, Alain Charest et al. · 2014 · Journal of Circulating Biomarkers
  61. Detection of Human c-Myc and EGFR Amplifications in Circulating Extracellular Vesicles in Mouse Tumour Models
    Leonora Balaj, Fatemeh Momen‐Heravi, Weilin Chen, Sarada Sivaraman, Xuan Zhang, Nicole Ludwig, Eckart U. Meese, Thomas D. Wurdinger, David P. Noske, Alain Charest et al. · 2014 · Journal of Circulating Biomarkers
  62. Comparative analysis of nucleic acid delivery systems for gene therapy: assessing viral and non-viral approaches with emphasis on extracellular vesicles
    Nizar Y. Saad · 2024 · Nucleic Acid Insights
  63. Non-viral gene therapy for neuromuscular diseases including Duchenne muscular dystrophy using nanovesicles derived from human cells
    Seung Wook Oh, Jinah Han, Sung‐Soo Park · 2024 · Rare Disease and Orphan Drugs Journal
  64. Extracellular vesicles as mediators of intercellular communication in human breast cancer progression
    Kerstin Menck · 2014
  65. Isolation of Biologically Active Extracellular Vesicles-Associated AAVs for Gene Delivery to the Brain by Size Exclusion Chromatography
    Carina Henriques, Miguel Monteiro Lopes, Patrícia Maia Correia de Albuquerque, David Rufino‐Ramos, Laetitia S. Gaspar, Diana Duarte Lobo, Kevin Leandro, Ana Carolina da Silva, Rafael Baganha, Sónia Duarte et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Isolation of Biologically Active Extracellular Vesicles-Associated AAVs for Gene Delivery to the Brain by Size Exclusion Chromatography
    Luís Pereira de Almeida, Carina Henriques, Miguel Monteiro Lopes, Patrícia Albuquerque, David Rufino‐Ramos, Laetitia S. Gaspar, Diana Duarte Lobo, Kevin Leandro, Ana Beatriz Gonçalves da Silva, Rafael Baganha et al. · 2023 · Research Square
  67. Optimization of an adeno-associated viral vector for epidermal keratinocytes in vitro and in vivo
    Qi Shen, Shogo Suga, Yuta Moriwaki, Du Zening, Emi Aizawa, Mutsumi Okazaki, Juan Carlos Izpisúa Belmonte, Yusuke Hirabayashi, Keiichiro Suzuki, Masakazu Kurita · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  68. Prevention and inhibition of adverse humoral immune response to gene therapy mediated by adeno-associated virus (AAV) vector
    Meliani, Amine · 2026
  69. Nanointerventions for Gene Therapy
    K. Uma Maheswari, Vadim V. Annenkov · 2018 · Springer eBooks
  70. Preparation and characterization of extracellular vesicles for cancer therapy
    H Saari · 2020 · Työväentutkimus Vuosikirja
  71. Engineered genetic tools for directed gene regulation
    Rafael Rinaldi Ferreira · 2021
  72. Cryo-EM reveals how adeno-associated virus engages its receptor AAVR and an investigation of the GPR108 ectodomain
    Mark Silveria · 2022
  73. Extracellular Vesicles: The Challenges on the Way and Engineering Perspectives
    Noha Attia, Heba G. Ibrahim, Heba Abdulla, Mohamed Mashal, Gustavo Puras, José Luís Pedraz · 2023 · Springer eBooks
  74. Prospects for anti-EVs therapy in the context of skin melanoma
    V. A. Sheetikov, Ekaterina N. Kosobokova · 2024 · Russian Journal of Biotherapy
  75. The path towards precision medicine: Next generation biotherapeutics and delivery strategies across the blood–brain barrier for the treatment of neurodegenerative diseases
    Jagdeep K. Sandhu, Karan Thakur, David Cai, Christine L. Péladeau, Melissa Hewitt, Wassim Ghadban · 2025 · Elsevier eBooks
  76. Rôle de CD146 dans l'athérosclérose
    Muriel G. Blin · 2016
  77. The role of extracellular vesicles and cross-dressing in graft rejection and tolerance : antigenicity and immunogenicity of allogeneic vesicles in mice
    Aurore Prunevieille · 2021
  78. Interactions between extracellular vesicles and viruses: lessons learned across species and kingdoms
    Kyra A. Y. Defourny, Paola Xhelili, İkbal Agah İnce, Fabrizio Cillo, Karolina Sapoń, Tadeusz Janas, Guy J. Smagghe, Erinda Lika, Amy H. Buck, Esther N. M. Nolte‐‘t Hoen et al. · 2026 · FEMS Microbiology Reviews
  79. Host determinants of exo-rAAV production revealed by extended gene expression analysis in HEK293 cells
    Jesús Lavado‐García, Laia Bosch-Molist, Carlos Ruiz-Ayala, Inmaculada Jorge, Jesús Vázquez, Francesc Gòdia, Laura Cervera · 2026 · Molecular Therapy Advances
  80. Engineered extracellular vesicles: pharmacological barriers, engineering strategies, and translational opportunities
    Jiao Xu, Zhi Li, Da Liu, Libo Zhao, Yongqing Li · 2026 · Extracellular Vesicles and Circulating Nucleic Acids
  81. Cancer cell membranes, tumor extracellular vesicles, and subcellular organelle targeting as promising biomimetic drug delivery systems
    Yan Chen, Hongtao Xiao, Hongwei Zhang, Nanxi Xiang, Chengyu Wu, Daniel Scherman, Sanjun Shi, Wei Tao · 2026 · The Innovation Drug Discovery
  82. Rapid and Efficient Affinity Isolation of Engineered Extracellular Vesicles Encapsulating Functional Proteins via Internal Twin‐Strep Tetraspanin Tagging
    M Pham, Jona Benjamin Krohn, Janis Meyer, Christian Ritter, Martin Schneider, Dominic Helm, Dario L. Frey, Kleopatra Rapti, Uta Haselmann-Weiß, Elif Toprak et al. · 2026 · Small